Mice immunised with synthetic peptide from N-terminal conserved region of merozoite surface antigen-2 of human malaria parasite Plasmodium falciparum can control infection induced by Plasmodium yoelii yoelii 265BY strain

By Lougovskoi A.A.   Okoyeh N.J.   Chauhan V.S.  

Vaccine, Vol. 18, Iss. 9, 1999-12 ,pp. : 920-930

Elsevier

Access to resources Recommend Favorite

A glycosylphosphatidylinositol anchor signal sequence enhances the immunogenicity of a DNA vaccine encoding Plasmodium falciparum sexual-stage antigen, Pfs230

By Fanning S.L.   Czesny B.   Sedegah M.   Carucci D.J.   van Gemert G.-J.   Eling W.   Williamson K.C.  

Vaccine, Vol. 21, Iss. 23, 2003-07 ,pp. : 3228-3235

Elsevier

Access to resources Recommend Favorite

Expression of malaria transmission-blocking vaccine antigen Pfs25 in Pichia pastoris for use in human clinical trials

By Zou L.   Miles A.P.   Wang J.   Stowers A.W.  

Vaccine, Vol. 21, Iss. 15, 2003-04 ,pp. : 1650-1657

Elsevier

Access to resources Recommend Favorite

Development, expression, and murine testing of a multistage Plasmodium falciparum malaria vaccine candidate

By Shi Y.P.   Das P.   Holloway B.   Udhayakumar V.   Tongren J.E.   Candal F.   Biswas S.   Ahmad R.   Hasnain S.E.   Lal A.A.  

Vaccine, Vol. 18, Iss. 25, 2000-06 ,pp. : 2902-2914

Elsevier

Access to resources Recommend Favorite

Preclinical evaluation of a synthetic Plasmodium falciparum MAP malaria vaccine in Aotus monkeys and mice

By Moreno C.A.   Rodriguez R.   Oliveira G.A.   Ferreira V.   Nussenzweig R.S.   Moya Castro Z.R.   Calvo-Calle J.M.   Nardin E.  

Vaccine, Vol. 18, Iss. 1, 1999-08 ,pp. : 89-99

Elsevier

Access to resources Recommend Favorite